These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2641037)

  • 1. Effects of triazolam (TZ) on matching-to-sample (MTS) performance in humans.
    Roache JD; Cherek DR; Cowan KA; Spiga R; Bennett RH; Grabowski J
    NIDA Res Monogr; 1989; 95():475-6. PubMed ID: 2641037
    [No Abstract]   [Full Text] [Related]  

  • 2. Triazolam and ethanol effects on human matching-to-sample performance vary as a function of pattern size and discriminability.
    Roache JD; Spiga R; Burt DB
    Drug Alcohol Depend; 1993 May; 32(3):219-29. PubMed ID: 8348874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thioridazine (Mellaril) on titrating delayed matching-to-sample performance of mentally retarded adults.
    Wysocki T; Fuqua W; Davis VJ; Breuning SE
    Am J Ment Defic; 1981 Mar; 85(5):539-47. PubMed ID: 7223785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human information-processing: some effects of methylphenidate, age, and scopolamine.
    Callaway E
    Biol Psychiatry; 1984 May; 19(5):649-62. PubMed ID: 6733179
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of triazolam and pentobarbital: performance impairment, subjective effects and abuse liability.
    Roache JD; Griffiths RR
    J Pharmacol Exp Ther; 1985 Jul; 234(1):120-33. PubMed ID: 2861282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human multioperant responding: effects of triazolam.
    Spiga R; Cherek DR; Meisch RA; Roache JD
    NIDA Res Monogr; 1989; 95():477-8. PubMed ID: 2641038
    [No Abstract]   [Full Text] [Related]  

  • 7. Discriminative-stimulus effects of triazolam in light and moderate drinkers.
    Rush CR; Kelly TH; Fillmore MT; Hays LR
    Alcohol Clin Exp Res; 2003 Apr; 27(4):638-46. PubMed ID: 12711926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects.
    Berlin I; Warot D; Hergueta T; Molinier P; Bagot C; Puech AJ
    J Clin Psychopharmacol; 1993 Apr; 13(2):100-6. PubMed ID: 8463441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional antagonism of the caffeine-discriminative stimulus by triazolam in humans.
    Oliveto AH; Bickel WK; Hughes JR; Higgins ST; Badger G
    Behav Pharmacol; 1997 Jun; 8(2-3):124-38. PubMed ID: 9833008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hashish on vigilance performance.
    Bahri T; Amir T
    Percept Mot Skills; 1994 Feb; 78(1):11-6. PubMed ID: 8177645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of triazolam and lorazepam on human learning, performance and subject ratings.
    Rush CR; Higgins ST; Bickel WK; Hughes JR
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1218-26. PubMed ID: 8450459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication may be required for the development of automatic information processing in schizophrenia.
    Serper MR; Bergman RL; Harvey PD
    Psychiatry Res; 1990 Jun; 32(3):281-8. PubMed ID: 2388967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of triazolam and ethanol on awareness, memory, and psychomotor performance.
    Roache JD; Cherek DR; Bennett RH; Schenkler JC; Cowan KA
    J Clin Psychopharmacol; 1993 Feb; 13(1):3-15. PubMed ID: 8486815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of flurazepam and triazolam on neuropsychological performance.
    Bornstein RA; Watson GD; Kaplan MJ
    Percept Mot Skills; 1985 Feb; 60(1):47-52. PubMed ID: 2858842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type.
    Sahakian B; Jones G; Levy R; Gray J; Warburton D
    Br J Psychiatry; 1989 Jun; 154():797-800. PubMed ID: 2597885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human psychopharmacology of intranasal cocaine.
    Higgins ST; Hughes JR; Bickel WK
    NIDA Res Monogr; 1989; 95():357-8. PubMed ID: 2701303
    [No Abstract]   [Full Text] [Related]  

  • 18. Vasopressin and amphetamine, but not desglycinamide vasopressin, impair positively reinforced visual attention performance in rats.
    Sahgal A
    Behav Brain Res; 1988 Jul; 29(1-2):35-42. PubMed ID: 3401320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of methylphenidate on levels of processing and laterality in children with attention deficit disorder.
    Malone MA; Kershner JR; Siegel L
    J Abnorm Child Psychol; 1988 Aug; 16(4):379-95. PubMed ID: 3221029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys.
    Schneider JS; Tinker JP; Van Velson M; Menzaghi F; Lloyd GK
    J Pharmacol Exp Ther; 1999 Aug; 290(2):731-9. PubMed ID: 10411585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.